New studies in vitro antibacterial evaluation and cell viability in PMMA-G-PEG 4000 derivatives with encapsulated Erythromycin.

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorAzevedo, Maria Luíza Schaefer-
Autor(es): dc.creatorRezende, Giselle A. S.-
Autor(es): dc.creatorSousa, Lucas Resende Dutra-
Autor(es): dc.creatorReis, Rúbia Castro Fernandes Melo-
Autor(es): dc.creatorNovack, Kátia Monteiro-
Autor(es): dc.creatorBarboza, Ana Paula Moreira-
Autor(es): dc.creatorNeves, Bernardo Ruegger Almeida-
Autor(es): dc.creatorAmparo, Tatiane Roquete-
Autor(es): dc.creatorTeixeira, Luiz Fernando de Medeiros-
Autor(es): dc.creatorVieira, Paula Melo de Abreu-
Autor(es): dc.creatorPerasoli, Fernanda Barçante-
Autor(es): dc.creatorSantos, Viviane Martins Rebello dos-
Data de aceite: dc.date.accessioned2025-08-21T15:17:11Z-
Data de disponibilização: dc.date.available2025-08-21T15:17:11Z-
Data de envio: dc.date.issued2023-01-25-
Data de envio: dc.date.issued2023-01-25-
Data de envio: dc.date.issued2021-
Fonte completa do material: dc.identifierhttp://www.repositorio.ufop.br/jspui/handle/123456789/16054-
Fonte completa do material: dc.identifierhttps://doi.org/10.21577/1984-6835.20220037-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1009205-
Descrição: dc.descriptionSynthetic polymers have been extensively studied in several areas of knowledge, one of which is the pharmaceutical. The drug when encapsultated into the PMMA-g-PEG 4000 matrix can produce fewer side effects. The most frequent side effects of erythromycin are gastrointestinal and are dose related. Nausea, vomiting and diarrhea occur in low frequency with the usual oral doses. The drug used in this study was Erythromycin, an antimicrobial that acts directly on bacterial protein synthesis. Erythromycin was encapsulated into PMMA-g-PEG 4000 derivatives. All copolymers afther encapsultaions were characterized and identified by atomic force microscopy (AFM). In vitro assays of release, antimicrobial activity and cytotoxicity were performed for the copolymers obtained. The copolymers PMMA-g-PEG 4000 HAL and PMMA-g-PEG 4000 ACET showed drug controlled release profiles. All PMMA-g-PEG 4000 derivatives showed antibacterial activity against Staphylococcus aureus and did not show a cytotoxic effect on human fibroblasts.-
Formato: dc.formatapplication/pdf-
Idioma: dc.languageen-
Direitos: dc.rightsaberto-
Direitos: dc.rightsThis is an open-access article distributed under the terms of the Creative Commons Attribution License. Fonte: o PDF do artigo.-
Palavras-chave: dc.subjectCopolymers-
Palavras-chave: dc.subjectControlled release-
Palavras-chave: dc.subjectAntibacterial activity-
Título: dc.titleNew studies in vitro antibacterial evaluation and cell viability in PMMA-G-PEG 4000 derivatives with encapsulated Erythromycin.-
Título: dc.titleNovos estudos de avaliação antibacteriana in vitro e viabilidade celular em PMMA-G-PEG 4000 derivados com Eritromicina encapsulada.-
Aparece nas coleções:Repositório Institucional - UFOP

Não existem arquivos associados a este item.